Kv2-IN-A1

Kv2-IN-A1 Struktur
689297-68-5
CAS-Nr.
689297-68-5
Englisch Name:
Kv2-IN-A1
Synonyma:
Kv2-IN-A1;ry785,Kv2-IN-A1;KV2 channel inhibitor-1;Kv-2-IN-A1,Kv2 IN A1,Kv2INA1;Benzenepropanamide, 3-chloro-β-methyl-N-[2-(4-thiazolyl)-1H-benzimidazol-6-yl]-;Benzenepropanamide, 3-chloro-β-methyl-N-[2-(4-thiazolyl)-1H-benzimidazol-6-yl]-
CBNumber:
CB54199211
Summenformel:
C20H17ClN4OS
Molgewicht:
396.89
MOL-Datei:
689297-68-5.mol

Kv2-IN-A1 Eigenschaften

Sicherheit

Kv2-IN-A1 Chemische Eigenschaften,Einsatz,Produktion Methoden

Kv2-IN-A1 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Kv2-IN-A1 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 31)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30255 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd
+86-18341751992 +86-15382112998
757984502@qq.com China 892 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
Wuhan Jingkang en Biomedical Technology Co., Ltd
+8613720134139
orders@jknbiochem.com China 4604 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4153 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9709 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
2853530910@QQ.com China 8011 62
Shanghai Rechem science Co., Ltd. 21-31433387 15618786686
sales@rechemscience.com China 2993 58

  • Kv2-IN-A1
  • Benzenepropanamide, 3-chloro-β-methyl-N-[2-(4-thiazolyl)-1H-benzimidazol-6-yl]-
  • ry785,Kv2-IN-A1
  • Kv-2-IN-A1,Kv2 IN A1,Kv2INA1
  • KV2 channel inhibitor-1
  • Benzenepropanamide, 3-chloro-β-methyl-N-[2-(4-thiazolyl)-1H-benzimidazol-6-yl]-
  • 689297-68-5
Copyright 2019 © ChemicalBook. All rights reserved